
Neurobit is building a Universal health analytics platform using sleep as a biomarker across age, gender and race.
Neurobit uses physiological signals collected during sleep to uncover these patterns. Using sleep as a biomarker, Neurobit is building a Universal health analytics platform with their state-of-the-art AI models, trained on over a trillion data points of multi-channel physiological data to operate across devices, signals and disease conditions.
2022
Jan | Strategic Partnership
Strategically partnered with over 150 universities and research clinics around the world with access to one of the worlds largest health dataset enabling neurobit to build state-of-art 20+ AI models.
Jun | Stepped into New Market
Expanded globally with HQ in New York,Times Square and operating units in Singapore and Bangalore.
2023
Jan | Product Launch
Completed 4 Clinical trials in Singapore and US with a major publication in high impact peer-reviewed Journal.
May | Stepped into New Market
Neurobit Digital Health Lab Launched to allow AI-enabled Self-health assessment for every Indian.
Oct | Strategic Partnership
Successfully integrated into the Ayushman Bharat Digital Mission (ABDM) ecosystem .
B2B
Hospital and Clinics focussed on Pulmonology, Cardiology and Neurology.
Client Segment
:
BioTech/BioPharmaceutical,
HealthTech / MedTech / Healthcare,
Software,
Insurance
Target Companies
:
Medium Enterprise,
Large Enterprise
Target Geography
:
Frequently Asked Questions